| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
sodium voltage-gated channel alpha subunit 8 | 0.510 | 0.731 | 1.00 |
|
disease | 0.900 | None | 0.971 | 35 | 8 | 2007 | 2020 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.650 | None | 0.875 | 8 | 1 | 2004 | 2018 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.600 | None | 0.908 | 76 | 7 | 1995 | 2019 | ||||||||
|
protocadherin 19 | 0.599 | 0.462 | 1.00 |
|
disease | 0.600 | definitive | 0.981 | 54 | 1 | 2008 | 2019 | ||||||||
|
solute carrier family 12 member 5 | 0.570 | 0.654 | 1.00 |
|
disease | 0.600 | None | 1.000 | 23 | 0 | 2002 | 2019 | ||||||||
|
solute carrier family 6 member 1 | 0.592 | 0.538 | 1.00 |
|
disease | 0.560 | None | 1.000 | 8 | 0 | 2002 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 1 | 0.477 | 0.808 | 1.00 |
|
disease | 0.500 | None | 0.977 | 175 | 14 | 2001 | 2020 | ||||||||
|
sodium voltage-gated channel alpha subunit 2 | 0.518 | 0.731 | 1.00 |
|
disease | 0.500 | None | 0.942 | 52 | 8 | 2003 | 2019 | ||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 2 | 0.626 | 0.615 | 1.00 |
|
disease | 0.500 | strong | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
potassium voltage-gated channel subfamily Q member 2 | 0.537 | 0.654 | 1.00 |
|
disease | 0.400 | None | 1.000 | 50 | 4 | 1998 | 2020 | ||||||||
|
cyclin dependent kinase like 5 | 0.522 | 0.692 | 1.00 |
|
disease | 0.400 | None | 0.975 | 40 | 2 | 2004 | 2019 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.400 | None | 0.974 | 38 | 5 | 1993 | 2020 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit gamma2 | 0.548 | 0.654 | 0.74 |
|
disease | 0.400 | definitive | 0.844 | 32 | 5 | 2001 | 2019 | ||||||||
|
syntaxin binding protein 1 | 0.532 | 0.692 | 1.00 |
|
disease | 0.400 | None | 0.931 | 29 | 1 | 2009 | 2019 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2A | 0.522 | 0.808 | 1.00 |
|
disease | 0.400 | None | 0.960 | 25 | 2 | 1999 | 2019 | ||||||||
|
TSC complex subunit 1 | 0.440 | 0.808 | 1.00 |
|
disease | 0.400 | None | 0.958 | 24 | 0 | 1998 | 2019 | ||||||||
|
proline rich transmembrane protein 2 | 0.448 | 0.808 | 0.58 |
|
disease | 0.400 | moderate | 0.955 | 22 | 0 | 2012 | 2019 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
disease | 0.400 | None | 0.818 | 22 | 9 | 2005 | 2020 | ||||||||
|
TSC complex subunit 2 | 0.439 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 17 | 0 | 1998 | 2019 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.400 | None | 1.000 | 14 | 0 | 1996 | 2019 | ||||||||
|
hyperpolarization activated cyclic nucleotide gated potassium channel 1 | 0.564 | 0.654 | 1.00 |
|
disease | 0.400 | None | 1.000 | 12 | 0 | 2003 | 2020 | ||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
disease | 0.400 | None | 1.000 | 12 | 4 | 2008 | 2018 | ||||||||
|
chromodomain helicase DNA binding protein 2 | 0.585 | 0.577 | 1.00 |
|
disease | 0.400 | None | 1.000 | 11 | 0 | 2012 | 2019 | ||||||||
|
contactin associated protein 2 | 0.530 | 0.846 | 2.9E-09 |
|
disease | 0.400 | None | 1.000 | 11 | 0 | 2008 | 2020 | ||||||||
|
glial fibrillary acidic protein | 0.421 | 0.885 | 1.5E-06 |
|
disease | 0.400 | None | 1.000 | 11 | 0 | 1999 | 2020 |